I have a CreLoxP mouse that expresses cre recombinase, upon treatment with tamoxifen with subsequent deletion of floxed genes. I will isolate alveolar, peritoneal and bone marrow macrophages from this mouse and aim to treat them in-vitro with tamoxifen (4-OHT; active metabolite). May you please help me by sending me some suggestions or links to previous literature etc with useful information on what I aim to do? Specific questions are as follows: 

What concentrations do I use the 4-OHT at?

How long do I leave the 4-OHT in the medium to ensure successful recombination?

Thank you,

Liberty

Similar questions and discussions